US 12,282,023 B2
Use of ZC3H12B gene or protein and method for establishing animal model of liver disease
Guijun Guan, Shanghai (CN); and Yuyang Chang, Shanghai (CN)
Assigned to SHANGHAI OCEAN UNIVERSITY, Shanghai (CN)
Filed by SHANGHAI OCEAN UNIVERSITY, Shanghai (CN)
Filed on Dec. 28, 2020, as Appl. No. 17/135,890.
Application 17/135,890 is a continuation of application No. PCT/CN2020/072609, filed on Jan. 17, 2020.
Prior Publication US 2021/0199661 A1, Jul. 1, 2021
Int. Cl. G01N 33/574 (2006.01); A01K 67/0275 (2024.01); G01N 33/68 (2006.01)
CPC G01N 33/57484 (2013.01) [A01K 67/0275 (2013.01); G01N 33/57438 (2013.01); G01N 33/6893 (2013.01); A01K 2217/075 (2013.01); G01N 2333/705 (2013.01); G01N 2400/40 (2013.01)] 2 Claims
 
1. A method for establishing an animal model of liver disease, comprising a step of knocking down expression of ZC3H12B gene or protein of an animal; and
wherein the animal is selected from lower to higher vertebrates other than human.